Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4203553
Max Phase: Preclinical
Molecular Formula: C42H55N7O11
Molecular Weight: 833.94
Molecule Type: Small molecule
Associated Items:
ID: ALA4203553
Max Phase: Preclinical
Molecular Formula: C42H55N7O11
Molecular Weight: 833.94
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN(CCO)/[N+]([O-])=N/Oc1cc(NCCOC(=O)[C@]23CCC(C)(C)C[C@H]2[C@H]2C(=O)C=C4[C@@]5(C)C=C(C#N)C(=O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]2(C)CC3)c([N+](=O)[O-])cc1[N+](=O)[O-]
Standard InChI: InChI=1S/C42H55N7O11/c1-37(2)11-13-42(36(53)59-18-15-44-27-19-31(60-45-49(58)46(8)16-17-50)29(48(56)57)20-28(27)47(54)55)14-12-41(7)34(26(42)23-37)30(51)21-33-39(5)22-25(24-43)35(52)38(3,4)32(39)9-10-40(33,41)6/h19-22,26,32,34,44,50H,9-18,23H2,1-8H3/b49-45-/t26-,32-,34-,39-,40+,41+,42-/m0/s1
Standard InChI Key: MEFHVKQHMWRFDH-XBWKYCLGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 833.94 | Molecular Weight (Monoisotopic): 833.3960 | AlogP: 6.77 | #Rotatable Bonds: 12 |
Polar Surface Area: 253.67 | Molecular Species: ACID | HBA: 14 | HBD: 2 |
#RO5 Violations: 3 | HBA (Lipinski): 18 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 2.84 | CX Basic pKa: | CX LogP: 4.36 | CX LogD: 6.38 |
Aromatic Rings: 1 | Heavy Atoms: 60 | QED Weighted: 0.06 | Np Likeness Score: 0.93 |
1. Kang F, Ai Y, Zhang Y, Huang Z.. (2018) Design and synthesis of new hybrids from 2-cyano-3,12-dioxooleana- 9-dien-28-oic acid and O2-(2,4-dinitrophenyl) diazeniumdiolate for intervention of drug-resistant lung cancer., 149 [PMID:29501947] [10.1016/j.ejmech.2018.02.062] |
Source(1):